Rutgers Cancer Institute researchers evaluated the frequency of SARS-CoV-2 RNA on various environmental surfaces and found extremely low detection of SARS-CoV-2 across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.
Multiple myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called Kahler disease, myelomatosis, and plasma cell myeloma.
Rutgers Cancer Institute Sarcoma and Soft Tissue Oncology program provides comprehensive multidisciplinary care to patients with soft tissue sarcomas, osteosarcoma, Ewing sarcoma, Kaposi sarcoma, uterine sarcomas, gastrointestinal stromal tumors (GIST) and others.
A Rutgers Cancer Institute collaboration with George Mason University received the U.S. Army’s Breast Cancer Research Program Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized treatments. Read more
